If you didn’t manage to join us for our webinar on the ‘game changer’ trials unveiled at the recent EHA25 virtual meeting, you can now watch it on demand.

Hosted by Dr Leanne Berkahn, President of the Haematology Society of Australia and New Zealand, our panel of experts presented the key trials covering myeloma, leukaemia and lymphoma and gave their insights into how the findings have implications for clinical practice in Australia and New Zealand.

Watch the video:

Listen to the podcast:

the limbic · EHA25 Virtual: Game changers for haematologists in Australia and New Zealand
Hosted by:

Doctor Leanne Berkahn: President, Haematology Society of Australia and New Zealand.  Clinical Haematologist, Auckland Hospital, New Zealand, Senior Lecturer in Haematology, Department of Molecular medicine and Pathology, University of Auckland.

With special guests:

Myeloma: Professor Andrew Spencer

Head of the Malignant Haematology and Stem Cell Transplantation Service at The Alfred Hospital, Professor of Haematology at Monash University, Head of the Myeloma Research Group and Co-Director of the ACRF Blood Cancer Therapeutics Centre at the Australian Centre for Blood Diseases, all in Melbourne.

Leukaemia: Associate Professor Anoop Enjeti

Senior Staff Specialist at Calvary Mater and Director of Haematology, NSW Health Pathology-John Hunter Hospital, Newcastle, Co-Chair of the ALLG Acute Leukaemia Working Party, MDS stream lead.

Lymphoma: Dr Tara Cochrane 

Clinical and Laboratory Haematologist, Gold Coast University Hospital,  Co-Chair of the ALLG’s Lymphoma Working Party, member of the ALLG Scientific Advisory Committee.

This webinar is an independent initiative of the limbic in collaboration with MSAG and ALLG.

Thank you to Janssen-Cilag Pty Ltd for providing the financial support that made this webinar possible.